|
|
|
Size
|
Re: Since when did case series become acceptable to prove efficacy?
|
Stephen Senn |
Fri, 1 Aug 2014 06:57:19 +0000 |
2722 lines |
Re: Since when did case series become acceptable to prove efficacy?
|
David P. Dillard |
Fri, 1 Aug 2014 12:32:47 -0400 |
976 lines |
Re: New Standard of Care Guidelines for Treating Lyme and Other Tick-borne Illnesses
|
Djulbegovic, Benjamin |
Fri, 1 Aug 2014 19:21:24 +0000 |
499 lines |
Re: Since when did case series become acceptable to prove efficacy?
|
Huw Llewelyn [hul2] |
Fri, 1 Aug 2014 21:20:27 +0000 |
2812 lines |
Re: Since when did case series become acceptable to prove efficacy?
|
Amy Price |
Fri, 1 Aug 2014 22:26:22 -0400 |
2341 lines |
Re: Since when did case series become acceptable to prove efficacy?
|
Stephen Senn |
Sat, 2 Aug 2014 11:38:48 +0200 |
2999 lines |
Evidence of benefits of diagnosing
|
Juan Gérvas |
Sat, 2 Aug 2014 11:52:00 +0200 |
51 lines |
Evidence Based Research Meets Digital Initiatives
|
David P. Dillard |
Sat, 2 Aug 2014 06:50:52 -0400 |
73 lines |
Statistical Data and the Paleo Diet
|
David P. Dillard |
Sat, 2 Aug 2014 12:56:59 -0400 |
110 lines |
Re: New Standard of Care Guidelines for Treating Lyme and Other Tick-borne Illnesses
|
Juan Gérvas |
Sat, 2 Aug 2014 19:19:18 +0200 |
238 lines |
Re: New Standard of Care Guidelines for Treating Lyme and Other Tick-borne Illnesses
|
healingjia Price |
Sat, 2 Aug 2014 21:44:18 -0400 |
182 lines |
Re: Since when did case series become acceptable to prove efficacy?
|
Huw Llewelyn [hul2] |
Sun, 3 Aug 2014 09:03:38 +0000 |
3456 lines |
Re: New Standard of Care Guidelines for Treating Lyme and Other Tick-borne Illnesses
|
Djulbegovic, Benjamin |
Sun, 3 Aug 2014 12:28:12 +0000 |
288 lines |
Re: Since when did case series become acceptable to prove efficacy?
|
Djulbegovic, Benjamin |
Sun, 3 Aug 2014 12:36:26 +0000 |
3496 lines |
Re: New Standard of Care Guidelines for Treating Lyme and Other Tick-borne Illnesses
|
Kate Bloor |
Sun, 3 Aug 2014 14:57:16 +0100 |
568 lines |
Re: Since when did case series become acceptable to prove efficacy?
|
Huw Llewelyn [hul2] |
Sun, 3 Aug 2014 13:59:47 +0000 |
3540 lines |
Re: New Standard of Care Guidelines for Treating Lyme and Other Tick-borne Illnesses
|
Brian Alper MD |
Sun, 3 Aug 2014 14:20:32 +0000 |
306 lines |
Re: New Standard of Care Guidelines for Treating Lyme and Other Tick-borne Illnesses
|
Brian Alper MD |
Sun, 3 Aug 2014 14:23:13 +0000 |
761 lines |
Re: New Standard of Care Guidelines for Treating Lyme and Other Tick-borne Illnesses
|
Kalipso Chalkidou |
Sun, 3 Aug 2014 15:56:28 +0100 |
1043 lines |
Re: New Standard of Care Guidelines for Treating Lyme and Other Tick-borne Illnesses
|
Amy Price |
Sun, 3 Aug 2014 11:00:40 -0400 |
1021 lines |
Re: New Standard of Care Guidelines for Treating Lyme and Other Tick-borne Illnesses
|
Andreas Lundh |
Sun, 3 Aug 2014 19:10:47 +0200 |
1183 lines |
Re: Since when did case series become acceptable to prove efficacy?
|
Djulbegovic, Benjamin |
Sun, 3 Aug 2014 17:41:43 +0000 |
3584 lines |
Re: New Standard of Care Guidelines for Treating Lyme and Other Tick-borne Illnesses
|
Birnbaum, David |
Sun, 3 Aug 2014 17:59:11 +0000 |
134 lines |
Re: Since when did case series become acceptable to prove efficacy?
|
Stephen Senn |
Sun, 3 Aug 2014 22:53:52 +0200 |
3137 lines |
Re: New Standard of Care Guidelines for Treating Lyme and Other Tick-borne Illnesses
|
Richard Saitz |
Sun, 3 Aug 2014 17:27:34 -0400 |
254 lines |
Re: Since when did case series become acceptable to prove efficacy?
|
Huw Llewelyn [hul2] |
Sun, 3 Aug 2014 22:47:22 +0000 |
3673 lines |
Re: An open letter for the people in Gaza, the Lancet
|
Richard Saitz |
Sun, 3 Aug 2014 18:56:21 -0400 |
151 lines |
Re: An open letter for the people in Gaza, the Lancet
|
healingjia Price |
Sun, 3 Aug 2014 19:46:23 -0400 |
188 lines |
Re: Since when did case series become acceptable to prove efficacy?
|
Djulbegovic, Benjamin |
Mon, 4 Aug 2014 02:28:07 +0000 |
3737 lines |
Re: Since when did case series become acceptable to prove efficacy?
|
Huw Llewelyn [hul2] |
Mon, 4 Aug 2014 07:32:59 +0000 |
3778 lines |
Evidence of no benefits of health checks
|
Juan Gérvas |
Mon, 4 Aug 2014 09:41:15 +0200 |
37 lines |
Re: An open letter for the people in Gaza, the Lancet
|
Suhail Doi |
Mon, 4 Aug 2014 10:37:13 +0100 |
20 lines |
Re: Since when did case series become acceptable to prove efficacy?
|
Djulbegovic, Benjamin |
Mon, 4 Aug 2014 10:53:12 +0000 |
3815 lines |
Re: Since when did case series become acceptable to prove efficacy?
|
Huw Llewelyn [hul2] |
Mon, 4 Aug 2014 17:08:34 +0000 |
3893 lines |
Re: Since when did case series become acceptable to prove efficacy?
|
Djulbegovic, Benjamin |
Mon, 4 Aug 2014 17:26:53 +0000 |
4005 lines |
Re: Since when did case series become acceptable to prove efficacy?
|
Huw Llewelyn [hul2] |
Mon, 4 Aug 2014 17:44:00 +0000 |
4034 lines |
Re: Since when did case series become acceptable to prove efficacy?
|
Huw Llewelyn [hul2] |
Mon, 4 Aug 2014 17:59:07 +0000 |
4063 lines |
Re: Since when did case series become acceptable to prove efficacy?
|
Djulbegovic, Benjamin |
Mon, 4 Aug 2014 18:14:21 +0000 |
4166 lines |
Re: New Standard of Care Guidelines for Treating Lyme and Other Tick-borne Illnesses
|
Benson, Teresa |
Mon, 4 Aug 2014 18:28:24 +0000 |
965 lines |
Re: Since when did case series become acceptable to prove efficacy?
|
Stephen Senn |
Mon, 4 Aug 2014 21:08:16 +0200 |
3498 lines |
Re: Since when did case series become acceptable to prove efficacy?
|
Djulbegovic, Benjamin |
Mon, 4 Aug 2014 19:19:06 +0000 |
4061 lines |
Re: Since when did case series become acceptable to prove efficacy?
|
Huw Llewelyn [hul2] |
Mon, 4 Aug 2014 19:30:06 +0000 |
4240 lines |
Re: Since when did case series become acceptable to prove efficacy?
|
Stephen Senn |
Mon, 4 Aug 2014 21:52:51 +0200 |
3635 lines |
Re: Since when did case series become acceptable to prove efficacy?
|
Huw Llewelyn [hul2] |
Mon, 4 Aug 2014 20:56:22 +0000 |
4215 lines |
On replying to mrssages [case series thread]
|
Ted Harding |
Mon, 4 Aug 2014 22:28:24 +0100 |
64 lines |
July 2014 newsletter of the International Society for Evidence-based Health Care
|
Paul Glasziou |
Tue, 5 Aug 2014 14:15:09 +1000 |
80 lines |
lyme disease guidelines
|
Kate Bloor |
Tue, 5 Aug 2014 17:10:48 +0100 |
135 lines |
changing email accounts
|
Ashley Graham Kennedy |
Tue, 5 Aug 2014 21:53:03 -0400 |
526 lines |
Evidence Live - Call for Abstracts
|
Ruth Davis |
Wed, 6 Aug 2014 07:54:45 +0000 |
568 lines |
statins guidelines and NICE (United Kingdom)
|
Juan Gérvas |
Wed, 6 Aug 2014 11:23:02 +0200 |
113 lines |
The BMJ versus Dr. Cholesterol. An updated.
|
Juan Gérvas |
Thu, 7 Aug 2014 18:06:31 +0200 |
588 lines |
New Social Policy MSc and other courses at Institute of Education
|
Philip Rose |
Fri, 8 Aug 2014 10:43:41 +0100 |
264 lines |
Re: The BMJ versus Dr. Cholesterol. An updated.
|
Juan Gérvas |
Fri, 8 Aug 2014 12:16:34 +0200 |
638 lines |
EBOLA: Current updated info/resources.
|
David |
Sun, 10 Aug 2014 12:54:48 -0600 |
36 lines |
Re: EBOLA: Current updated info/resources.
|
David P. Dillard |
Sun, 10 Aug 2014 23:08:06 -0400 |
61 lines |
Online Course: New Capabilities in PLS Path Modeling with SmartPLS 3.0 and PLS-GUI
|
Geoffrey Hubona |
Mon, 11 Aug 2014 07:18:47 -0700 |
32 lines |
Two job opportunities: Senior Research Fellow/Research Fellow in Healthcare Modelling
|
Shepherd J.P. |
Tue, 12 Aug 2014 11:55:34 +0000 |
204 lines |
JOBS: School of Social and Community Medicine, University of Bristol
|
Julian Higgins |
Tue, 12 Aug 2014 15:19:38 +0100 |
117 lines |
Online 3-Credit Sept-Oct PhD Course on Statistical Analyses and SEM
|
Geoffrey Hubona |
Tue, 12 Aug 2014 18:06:57 -0700 |
23 lines |
Videos from the EQUATOR meeting and Annual Lecture
|
Iveta Simera |
Thu, 14 Aug 2014 10:00:50 +0100 |
63 lines |
Selling screening programs
|
Juan Gérvas |
Thu, 14 Aug 2014 11:33:40 +0200 |
13 lines |
How much money do we waste on research?
|
Iveta Simera |
Fri, 15 Aug 2014 09:51:28 +0100 |
73 lines |
Last remaining places on research methods courses at the EPPI-Centre, Institute of Education, University of London
|
Philip Rose |
Mon, 18 Aug 2014 11:30:02 +0100 |
267 lines |
Online Course: New Capabilities in PLS Path Modeling with SmartPLS 3.0 and PLS-GUI
|
Geoffrey Hubona |
Mon, 18 Aug 2014 18:40:21 -0700 |
32 lines |
U.S. Women Are Dying Younger Than Their Mothers
|
Juan Gérvas |
Tue, 19 Aug 2014 11:27:31 +0200 |
108 lines |
R-Courseware: 38 courses on R software, 12 month, 24/7 access
|
Geoffrey Hubona |
Tue, 19 Aug 2014 06:16:35 -0700 |
26 lines |
How Feedback Biases Give Ineffective Medical Treatments a Good Reputation
|
Jon Brassey |
Thu, 21 Aug 2014 16:00:14 +0100 |
117 lines |
Now with citation: How Feedback Biases Give Ineffective Medical Treatments a Good Reputation
|
Jon Brassey |
Thu, 21 Aug 2014 16:12:06 +0100 |
49 lines |
Evidence-Based risk communication?
|
Juan Gérvas |
Fri, 22 Aug 2014 12:49:14 +0200 |
38 lines |
Dementia screening
|
Hilda Bastian |
Wed, 27 Aug 2014 01:32:19 -0400 |
32620 lines |
Evidence to Support the Adoption of New Biomarkers
|
Ruth Davis |
Wed, 27 Aug 2014 15:14:29 +0000 |
238 lines |
Re: Dementia screening
|
Amy Price |
Wed, 27 Aug 2014 17:11:49 -0400 |
34509 lines |
fever, evidence-based treatment
|
Juan Gérvas |
Thu, 28 Aug 2014 14:16:53 +0200 |
75 lines |
Re: fever, evidence-based treatment
|
Tom Jefferson |
Thu, 28 Aug 2014 16:10:35 +0200 |
111 lines |
Re: fever, evidence-based treatment
|
Alfredo Serrano Moraza |
Thu, 28 Aug 2014 21:23:50 +0200 |
390 lines |
Clinical trial data transparency – making the commitment - A Shot in the Arm
|
Richard Hockey |
Fri, 29 Aug 2014 00:46:28 +0000 |
95 lines |
Re: fever, evidence-based treatment
|
Wouter Havinga |
Fri, 29 Aug 2014 09:01:26 +0100 |
22 lines |
FW: Live Advert: Senior Research Fellow in Evidence Synthesis for Communicable Disease Control
|
Clarke, Aileen |
Fri, 29 Aug 2014 14:12:48 +0000 |
402 lines |